New York Stem Cell Foundation Inc logo

New York Stem Cell Foundation Inc

NEW YORK, NY EIN: 20-2905531 Website

The New York Stem Cell Foundation (NYSCF) is a 501(c)(3) nonprofit research institute headquartered on the far west side of Manhattan in New York City. Founded in 2005, NYSCF operates as an independent research organization focused on stem cell research, technology development, and funding early-career investigators and postdoctoral fellows. The organization employs 164 staff members, including scientists, technicians, engineers, and administrative personnel. Since its inception, NYSCF has raised and invested more than $400 million for stem cell research.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$82.9M

-11.3% YoY

Annual Giving

$7.3M

-12.3% YoY

Grant Count

23

+4.5% YoY

Avg Grant Size

$318K

-16.1% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

NYSCF's mission is to accelerate cures for major diseases of our time through stem cell research. The organization was founded in response to the need for robust stem cell research investment and initially focused on type 1 diabetes research.

The foundation currently maintains disease research focuses in:

  • Alzheimer's Disease
  • Autism Spectrum Disorder
  • Diabetes
  • Macular Degeneration
  • Multiple Sclerosis
  • Parkinson's Disease
  • Psychiatric Disease
  • Women's Reproductive Cancers

Grantmaking

NYSCF provides fellowships and grants to support stem cell research. Recent grant activity shows:

Average Grant

amount:** $7,312–$961,000

Ready to take the next step with New York Stem Cell Foundation Inc?

Geographic Focus

Where this funder awards grants

NYSCF's grantmaking priorities include Massachusetts, New York, and California.

Grant Distribution by State

13states
+5 more states

Cities

BerkeleyBostonBronxCambridgeChapel HillCincinnatiClevelandCotton HeightsDallasEvansonEvanstonHackensackIthacaLos AngelesMadisonMenlo ParkNew HavenNew YorkOaklandPasadena

Financial History

Multi-year comparison from IRS filings

As of 2024:

  • Total Assets: $82,924,502
  • Total Revenue: $23,063,063
  • Total Expenses: $44,407,596
  • Total Liabilities: $59,000,000 (as of 2023)

Historical Financial Data:

  • 2023 Revenue: $30.4M
  • 2023 Expenses: $43.5M
  • 2023 Total Assets: $93.4M
Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$12M$24M$37M$49M20202021202220232024
Metric202420232022
Total Assets$82,924,502$93,436,824$68,785,441
Revenue$23,063,063$30,392,844$37,512,270
Expenses$44,407,596$43,475,154$41,703,809
Qualifying Distributions
Net Investment Income$104,026$65,325$2,574
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$2M$4M$6M$8M22 grants202021 grants202127 grants202222 grants202323 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

HARVARD COLLEGE$961KPRINCETON UNIVERSITY$600KUNIVERSITY OF CALIFORNIA…$600KCOLUMBIA UNIVERSITY$385KMASSACHUSETTS GENERAL HO…$361KMEMORIAL SLOAN-KETTERING…$361KBOSTON CHILDREN'S HOSPITAL$300KBROAD INSTITUTE$300KCALIFORNIA INSTITUTE OF …$300KDANA FARBER CANCER INSTI…$300K

Grant Size Distribution

115 grants across all recorded years

5<$50K21$50–100K7$100–250K55$250–500K25$500K–1M2$1–5M$5M+

Open Grants

4 open opportunities from New York Stem Cell Foundation Inc

Show all 4 →

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

  • Founder: Susan L. Solomon (lawyer and entrepreneur) and Mary Elizabeth Bunzel (former journalist)
  • CEO: Derrick J. Rossi, PhD

Compensation Overview

From 2024 IRS filing

JEFFREY WALLERSTEINCFO & COO$601KDANIEL PAULLVICE PRESIDENT, STEM CELL TE…$372KFREDERICK MONSMASENIOR VICE PRESIDENT, SCIEN…$318KCHRISTINE LINCHIEF ADVANCEMENT OFFICER$314KSIMI AHMEDSENIOR VICE PRESIDENT, STRAT…$295KSCOTT NOGGLESENIOR VICE PRESIDENT, RESEA…$288K

From 2024 filing

NameTitleHoursCompensation
ROY GERONEMUSCHAIRMAN & DIRECTOR6
MARGO ALEXANDERTREASURER & DIRECTOR6
DERRICK ROSSIDIRECTOR & ACTING CEO (UNTIL 1/7/24)3
KAREN BURKEDIRECTOR3
FRANCESCO CLARKDIRECTOR3
RICHARD J MASSEYDIRECTOR3
PAUL GOLDBERGERDIRECTOR3
PAUL M MEISTERDIRECTOR3
SIDDHARTHA MUKHERJEEDIRECTOR3
STEPHEN M ROSSDIRECTOR3
KAY UNGERDIRECTOR3
STEPHEN M SCHERRDIRECTOR3
CLYDE WILLIAMSDIRECTOR3
MARILYN BRESLOWDIRECTOR3
GEORGE LAZARUSDIRECTOR3
PEGGY BRIMDIRECTOR3
JENNIFER RAAB SEE SCH OPRESIDENT AND CEO (1/8/24)40
JEFFREY WALLERSTEINCFO & COO40$601,218
DANIEL PAULLVICE PRESIDENT, STEM CELL TECHNOLOGY PLATFORMS40$372,378
FREDERICK MONSMASENIOR VICE PRESIDENT, SCIENTIFIC OPERATIONS40$317,695
CHRISTINE LINCHIEF ADVANCEMENT OFFICER40$314,283
SIMI AHMEDSENIOR VICE PRESIDENT, STRATEGIC PARTNERSHIPS40$295,196
SCOTT NOGGLESENIOR VICE PRESIDENT, RESEARCH40$288,010

Recent News & Activity

Recent developments and announcements

NYSCF received a $27 million grant from the Robertson Foundation to promote stem cell research. The organization has also expanded its research capabilities through a pioneering alliance with The Jackson Laboratory, which ushers in a new era of predictive biomedical research by combining complementary scientific strengths in mouse genetics, human stem cell systems, and data science.

The New York Stem Cell Foundation Receives $27 Million Grant From Robertson

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with New York Stem Cell Foundation Inc on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities